The following resources provide additional context across different evaluation frameworks: A 2026 informational overview examining MEDVi's compounded tirzepatide GLP-1 telehealth program, regulatory classification, and pricing disclosures provides additional context on the platform's tirzepatide-specific offerings and enrollment considerations
That said, all of the studies have the same message: currently there is not enough evidence to prove that GLP-1 medications increase the risk of depression or suicidality
What are signs of over-dose
No single routine blood test diagnoses gastroparesis
The litigation currently remains in the discovery phase, with both sides exchanging documents, relevant medical records, and expert reports
This way, Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) help you lose weight by taming your hunger, slowing down digestion, and making you feel fuller after meals